Zenith Drugs Limited operates as a pharmaceutical manufacturing and trading company in India and internationally. The company offers products in the areas of electrolytes, analgesic, antipyretic, NSAIDs, anti-inflammatory, antiemetic, cold, cough, antihistaminic and antiasthmatic, antibacterial, antifungal, anti-infective, antiparasitic, antiviral, anthelmintic, anti-scabies, antimicrobial, antimalarial, disinfectant, antiseptic, corticosteroids, depigmenting agents, gastrointestinal, liver, kidney, skin care, antibiotic preparations, nutrition supplements, and others. It also provides a range of formulations in various forms, such as ORS powder, liquid orals, ointments, creams, gels, tablets, liquid externals, and capsules. The company was incorporated in 2000 and is based in Indore, India.
Metrics to compare | ZENH | Peers Peers - average of corresponding metrics from companies closely matching ZENH: 531240, MOREPENLAB, KOPRAN, 540694, 524790 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipZENHPeersSector |
---|---|---|---|---|
P/E Ratio | - | 18.2x | −0.5x | |
PEG Ratio | - | 0.23 | 0.00 | |
Price/Book | - | 3.7x | 2.6x | |
Price / LTM Sales | - | 2.8x | 3.0x | |
Upside (Analyst Target) | - | 15.8% | 54.1% | |
Fair Value Upside | Unlock | −1.6% | 8.7% | Unlock |